« Previous
Next »
Subjects
- Proprotein Convertases -- economics1
- Prospective Payment System1
- Protein Kinase Inhibitors -- economics1
- Protein Kinase Inhibitors -- therapeutic use1
- Protein-Tyrosine Kinases -- antagonists & inhibitors1
- Randomized Controlled Trials as Topic1
- Reimbursement Mechanisms -- economics1
- Serine Endopeptidases -- economics1
- Technology Assessment, Biomedical1
- Tetrazoles -- administration & dosage1
- Tetrazoles -- economics1
- Treatment Outcome1
- United States5
- Valsartan -- administration & dosage1
- Valsartan -- economics1
- Value-Based Purchasing2